GGrantIndex
← Leaderboards

Peter Storz

Mayo Clinic Jacksonville

$8,765,723
Attributed
$8,765,723
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,765,723 · 10

By mechanism

R01$6,810,910 · 5
R21$1,954,813 · 5

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Mediating

Research focus

MediatingCellsMalignant Neoplasm Of PancreasPancreatic Ductal AdenocarcinomaMalignant NeoplasmsGenerationsEventMutationIn VivoPancreasAnimal ModelTumorSignal TransductionLesionNeoplastic CellOncogenicProtein KinaseMolecularPhosphotransferasesBaseAcinar CellSurvival RateMacrophageAffect

Grant awards (31)

Protein Kinase D1 as a switch from acute to chronic pancreatitis$340,388
R01 · FY2025 · DK · contact PI
Deiminated molecules as markers for developing pancreatic cancer - A1$219,491
R21 · FY2025 · CA · contact PI
Protein Kinase D1 as a switch from acute to chronic pancreatitis$340,388
R01 · FY2024 · DK · contact PI
Deiminated molecules as markers for developing pancreatic cancer - A1$182,909
R21 · FY2024 · CA · contact PI
Role of ICAM1 in development and progression of pancreatic cancer$350,834
R01 · FY2023 · CA · contact PI
Role of ICAM1 in development and progression of pancreatic cancer$350,834
R01 · FY2022 · CA · contact PI
Role of ICAM1 in development and progression of pancreatic cancer$357,994
R01 · FY2021 · CA · contact PI
PKD1 signaling in the initiation of pancreatic cancer$145,771
R01 · FY2021 · CA · contact PI
Smoking carcinogen-induced initiation of pancreatic cancer$402,400
R21 · FY2020 · CA · contact PI
PKD1 signaling in the initiation of pancreatic cancer$357,994
R01 · FY2020 · CA · contact PI
Role of ICAM1 in development and progression of pancreatic cancer$357,994
R01 · FY2020 · CA · contact PI
Role of ICAM1 in development and progression of pancreatic cancer$357,994
R01 · FY2019 · CA · contact PI
PKD1 signaling in the initiation of pancreatic cancer$347,253
R01 · FY2019 · CA · contact PI
Targeting chemoresistance in ovarian cancer$177,420
R21 · FY2019 · CA · contact PI
Targeting chemoresistance in ovarian cancer$219,491
R21 · FY2018 · CA · contact PI
PKD1 signaling in the initiation of pancreatic cancer$212,223
R01 · FY2018 · CA · contact PI
PKD1 signaling in the initiation of pancreatic cancer$357,994
R01 · FY2017 · CA · contact PI
PKD1 signaling in the initiation of pancreatic cancer$357,994
R01 · FY2016 · CA · contact PI
Targeting Protein Kinase D in Triple Negative Breast Cancers$204,233
R21 · FY2016 · CA · contact PI
Targeting Protein Kinase D in Triple Negative Breast Cancers$170,194
R21 · FY2015 · CA · contact PI
Protein Kinase D in oncogenic oxidative stress signaling$298,713
R01 · FY2014 · CA · contact PI
Protein Kinase D in oncogenic oxidative stress signaling$289,474
R01 · FY2013 · CA · contact PI
Role of Protein Kinase D in Actin Remodeling and Cell Motiliy$255,795
R01 · FY2013 · GM · contact PI
Protein Kinase D in oncogenic oxidative stress signaling$307,951
R01 · FY2012 · CA · contact PI
Role of Protein Kinase D in Actin Remodeling and Cell Motiliy$265,073
R01 · FY2012 · GM · contact PI
Protein Kinase D in oncogenic oxidative stress signaling$307,951
R01 · FY2011 · CA · contact PI
Role of Protein Kinase D in Actin Remodeling and Cell Motiliy$265,073
R01 · FY2011 · GM · contact PI
Protein Kinase D in oncogenic oxidative stress signaling$317,475
R01 · FY2010 · CA · contact PI
Role of Protein Kinase D in Actin Remodeling and Cell Motiliy$267,750
R01 · FY2010 · GM · contact PI
Role of Protein Kinase D in Pancreatic Cancer$172,125
R21 · FY2009 · CA · contact PI
Role of Protein Kinase D in Pancreatic Cancer$206,550
R21 · FY2008 · CA · contact PI